Preeclampsia is a disorder that generally develops late in pregnancy, after week 20, and is characterized by a sudden onset of high blood pressure, severe swelling of the hands and face, and signs that some organs may not be working normally, including protein in the urine.
Global Pre-Eclampsia Disease Treatment Market: Introduction
- Preeclampsia is a disorder that generally develops late in pregnancy, after week 20, and is characterized by a sudden onset of high blood pressure, severe swelling of the hands and face, and signs that some organs may not be working normally, including protein in the urine.
Read Report Overview - https://www.transparencymarketresearch.com/preeclampsia-disease-treatment-market.html
- Regular blood and urine tests, such as assessing platelet counts, liver enzymes, kidney function, and urinary protein levels to determine if the condition is progressing, are the main factors for diagnosis of pre-eclampsia disease. Pre-eclampsia can cause the placenta to detach and/or the baby to be born too early, increasing the risk of health issues for the baby soon after birth. When preeclampsia becomes severe, it can cause serious complications for the mother and the fetus.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=80351
Key Drivers of Global Pre-Eclampsia Disease Treatment Market
Rising incidences of pre-eclampsia globally
- The incidence of pre-eclampsia, a precursor to eclampsia, varies greatly worldwide. WHO estimates the incidence of preeclampsia to be seven times higher in developing countries (2.8% of live births) than in developed countries (0.4%). According to American Heart Association, Inc., the greatest morbidity and mortality, preeclampsia affects 5% to 7% of all pregnant women; however, it is responsible for over 70 000 maternal deaths and 500 000 fetal deaths worldwide every year.
- According to Swiss Medical Weekly, risks for developing pre-eclampsia include nulliparity, prior pre-eclampsia, pre-existing hypertension, renal disease, gestational or pre-existing diabetes mellitus, and a family history of pre-eclampsia, maternal age of ≥35 years, multiple gestation, obesity, and a long interpregnancy interval.
Request for Analysis of COVID-19 Impact on Pre-Eclampsia Disease Treatment Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=80351
Rise in Prevalence of Lifestyle Diseases
- According to the American Diabetes Association, cardiovascular disease (including stroke), cancer, and diabetes account for approximately two-thirds of the total deaths in the U.S. and US$ 700 billion in direct and indirect economic costs each year. These diseases undermine health, shorten life expectancy, cause enormous suffering and disability, and incur high economic cost. The doctor may recommend a daily low-dose aspirin (81 milligrams) beginning after 12 weeks of pregnancy. Patients also might benefit from calcium supplements to prevent preeclampsia.
North America to Account for Major Share of Global Pre-Eclampsia Disease Treatment Market
- North America is projected to account for major share of the global pre-eclampsia disease treatment market during the forecast period. The market in the region is anticipated to expand at a rapid pace in the next few years due to an increase in research & development. Europe is expected to be the second-largest market owing to rise in incidence of preeclampsia in the region during the forecast period. Governments of countries in Europe are focused on launching awareness programs for prevention of preeclampsia, and diagnostics and treatment of women suffering from the disease.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=80351
- The pre-eclampsia disease treatment market in Asia Pacific is likely to expand at a high CAGR during the forecast period. Rise in demand for newer and advanced diagnostics tools, increase in research and development programs, and participation of governments in creating awareness about the disease are expected to boost the market in the region during the forecast period.
Pre Book Pre-Eclampsia Disease Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=80351<ype=S
Key Players Operating in Global Pre-Eclampsia Disease Treatment Market
The global pre-eclampsia disease treatment market is highly consolidated owing to the presence of several key players. Leading players operating in the global pre-eclampsia disease treatment market include:
- F. Hoffmann-La Roche Ltd
- PerkinElmer Inc.
- DRG INSTRUMENTS GMBH
- Thermo Fisher Scientific Inc.
- Diabetomics, Inc.
- Metabolomic Diagnostics Ltd.
- Sera Prognostics
- Siemens Healthineers AG
- Bayer
Browse More Trending Reports by Transparency Market Research:
Antibody Fragments Market: https://www.transparencymarketresearch.com/antibody-fragments-market.html
Tele-Care Market: https://www.transparencymarketresearch.com/tele-care-market.html
Drug Intermediate Market: https://www.transparencymarketresearch.com/drug-intermediate-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/